BRIEF-Vertex Pharmaceuticals Q4 Operating Income USD 1,026 Million

Reuters
11 Feb
BRIEF-Vertex Pharmaceuticals Q4 Operating Income USD 1,026 Million

Feb 10 (Reuters) - Vertex Pharmaceuticals Q4 net income USD 913 million.

  • Q4 revenue USD 2,912 million vs. IBES estimate USD 2,780 million
  • Q4 pretax profit USD 1,136.5 million vs. IBES estimate USD 1,287 million
  • outlook FY product revenue USD 11,020 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10